Events | News

IDL Diagnostics participates at RedEye Theme Event Fight Cancer

Feb 2, 2026

On January 21st Redeye hosted a Fight Cancer 2026 theme event where CEO Anders Hultman presented about the company, market opportunities and the new strategic priority.

See the presentation here

 

Gustav Sten appointed CEO of IDL Diagnostics

IDL Diagnostics today announces that the Board of Directors has appointed Gustav Sten as the new Chief Executive Officer (CEO). Gustav Sten will assume the position on May 28, immediately following the Annual General Meeting, succeeding Anders Hultman.  Gustav Sten...

read more

Healthcare day 2026

On April 14, IDL participated at Redeye Healthcare Day. CEO Anders Hultman presented the company and shared more about its strategy, current and future markets, and our joint venture with concile. Watch the presentation here

read more